Afzal Sheryar, Abdul Manap Aimi Syamima, Attiq Ali, Albokhadaim Ibrahim, Kandeel Mahmoud, Alhojaily Sameer M
Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.
Discipline of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Malaysia.
Front Pharmacol. 2023 Oct 18;14:1269581. doi: 10.3389/fphar.2023.1269581. eCollection 2023.
Increased production and buildup of reactive oxygen species (ROS) can lead to various health issues, including metabolic problems, cancers, and neurological conditions. Our bodies counteract ROS with biological antioxidants such as SOD, CAT, and GPx, which help prevent cellular damage. However, if there is an imbalance between ROS and these antioxidants, it can result in oxidative stress. This can cause genetic and epigenetic changes at the molecular level. This review delves into how ROS plays a role in disorders caused by oxidative stress. We also look at animal models used for researching ROS pathways. This study offers insights into the mechanism, pathology, epigenetic changes, and animal models to assist in drug development and disease understanding.
活性氧(ROS)生成增加及其积累会导致各种健康问题,包括代谢问题、癌症和神经疾病。我们的身体会用超氧化物歧化酶(SOD)、过氧化氢酶(CAT)和谷胱甘肽过氧化物酶(GPx)等生物抗氧化剂来对抗ROS,这些抗氧化剂有助于防止细胞损伤。然而,如果ROS与这些抗氧化剂之间存在失衡,就会导致氧化应激。这会在分子水平上引起基因和表观遗传变化。本综述深入探讨了ROS在由氧化应激引起的疾病中所起的作用。我们还研究了用于研究ROS途径的动物模型。这项研究为机制、病理学、表观遗传变化和动物模型提供了见解,以协助药物开发和疾病理解。